Long-term predictive value of postsurgical cortisol concentrations for cure and risk of recurrence in Cushing's disease

被引:132
作者
Pereira, AM
van Aken, MO
van Dulken, H
Schutte, PJ
Biermasz, NR
Smit, JWA
Roelfsema, F
Romijn, JA
机构
[1] Leiden Univ, Med Ctr, Dept Endocrinol & Metab, NL-2300 RC Leiden, Netherlands
[2] Leiden Univ, Med Ctr, Dept Neurosurg, NL-2300 RC Leiden, Netherlands
关键词
D O I
10.1210/jc.2003-030751
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We assessed the value of postoperative plasma cortisol concentrations to predict cure and recurrence of Cushing's disease after transsphenoidal surgery (TS). Seventy-eight of 80 consecutive patients treated by TS for Cushing's disease were evaluated. TS cured 72% ( n = 56) of the patients. Two weeks after surgery, patients with plasma cortisol levels below 138 nmol/liter ( n = 50; three macroadenomas) and eight (27%) of 30 patients ( nine macroadenomas) with cortisol greater than 138 nmol/liter were cured. Six ( five with a macroadenoma) of these eight patients had cortisol values less than 50 nmol/liter 3 months after surgery. Therefore, the optimal cut-off value of cortisol predicting remission was 138 nmol/liter, measured 3 months after surgery ( positive and negative predictive values 87 and 90%, respectively). Five patients (9%) had recurrent Cushing's disease during a median follow-up of 7 yr. Recurrence occurred in four of 24 (17%) patients with a follow-up of more than 10 yr. Therefore, cortisol levels above 138 nmol/liter, obtained 2 wk after TS, should be repeated, because they do not predict persistent Cushing's disease in 27% of those patients. Postoperative cortisol levels do not positively predict recurrence of disease during long-term follow-up of initially cured patients.
引用
收藏
页码:5858 / 5864
页数:7
相关论文
共 21 条
[1]   Adrenocorticotropin and cortisol hyperresponsiveness to hexarelin in patients with Cushing's disease bearing a pituitary microadenoma, but not in those with macroadenoma [J].
Arvat, E ;
Giordano, R ;
Ramunni, J ;
Arnaldi, G ;
Colao, A ;
Deghenghi, R ;
Lombardi, G ;
Mantero, F ;
Camanni, F ;
Ghigo, E .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (12) :4207-4211
[2]   CONTINUOUS DEXAMETHASONE INFUSION FOR 7 HOURS IN PATIENTS WITH THE CUSHING SYNDROME - A SUPERIOR DIFFERENTIAL DIAGNOSTIC-TEST [J].
BIEMOND, P ;
DEJONG, FH ;
LAMBERTS, SWJ .
ANNALS OF INTERNAL MEDICINE, 1990, 112 (10) :738-742
[3]   Ten-year follow-up results of transsphenoidal microsurgery in acromegaly [J].
Biermasz, NR ;
Van Dulken, H ;
Roelfsema, F .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (12) :4596-4602
[4]   Outcomes of therapy for Cushing's disease due to adrenocorticotropin-secreting pituitary macroadenomas [J].
Blevins, LS ;
Christy, JH ;
Khajavi, M ;
Tindall, GT .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (01) :63-67
[5]  
BOGGAN JE, 1983, J NEUROSURG, V59, P1995
[6]  
Buchfelder M, 1991, Acta Neurochir Suppl (Wien), V53, P72
[7]   Transsphenoidal pituitary surgery in Cushing's disease: can we predict outcome? [J].
Chee, GH ;
Mathias, DB ;
James, RA ;
Kendall-Taylor, P .
CLINICAL ENDOCRINOLOGY, 2001, 54 (05) :617-626
[8]   The complete normalization of the adrenocortical function as the criterion of cure after transsphenoidal surgery for Cushing's disease [J].
Estrada, J ;
García-Uría, J ;
Lamas, C ;
Alfaro, J ;
Lucas, T ;
Diez, S ;
Salto, L ;
Barceló, B .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (12) :5695-5699
[9]   TRANS-SPHENOIDAL SURGERY FOR CUSHINGS-DISEASE [J].
FAHLBUSCH, R ;
BUCHFELDER, M ;
MULLER, OA .
JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 1986, 79 (05) :262-269
[10]  
Knappe U J, 1996, Acta Neurochir Suppl, V65, P31